Matches in Nanopublications for { ?s ?p ?o <https://w3id.org/np/RAhQ2NCKoHIAiGhiCj7I-OnT60i1t4QquUFt11u32PnTI/assertion>. }
- 0000-0002-2736-0052 type Agent assertion.
- mailto:service-account-generation-service type Agent assertion.
- -864102085 type Domain assertion.
- -900704710 type Domain assertion.
- -503298211 type Organization assertion.
- 1716096478 type Domain assertion.
- -114853210 type Domain assertion.
- 100007899 type Concept assertion.
- 100012167 type Concept assertion.
- enrichment_service-account-enrichment type Agent assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 type BibliographyResearchObject assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 type BibliographyResearchObject assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 type ResearchObject assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 type LiveRO assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 type Dataset assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 type Resource assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 type MediaObject assertion.
- ro-crate-metadata.json type CreativeWork assertion.
- -1411647711 type Organization assertion.
- -488591808 type Organization assertion.
- 100001903 type Concept assertion.
- 100007917 type Concept assertion.
- 100008085 type Concept assertion.
- 100012171 type Concept assertion.
- 100029579 type Concept assertion.
- 100062567 type Concept assertion.
- 100203566 type Concept assertion.
- 100261358 type Concept assertion.
- 100372047 type Concept assertion.
- 1004117762 type Expression assertion.
- 100418554 type Concept assertion.
- 100844491 type Concept assertion.
- 12729093 type Concept assertion.
- 1331066068 type Place assertion.
- 1467821658 type Expression assertion.
- 150952 type Concept assertion.
- 1546953523 type Expression assertion.
- 184943978 type Expression assertion.
- 1943149042 type Expression assertion.
- 2029915868 type Expression assertion.
- 2101478199 type Place assertion.
- 373759660 type Expression assertion.
- 64445067 type Place assertion.
- 665713134 type Expression assertion.
- 4921 type DefinedTerm assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 description "COVID-19 is a disease with unique characteristics that include lung thrombosis(1), frequent diarrhoea(2), abnormal activation of the inflammatory response(3) and rapid deterioration of lung function consistent with alveolar oedema(4). The pathological substrate for these findings remains unknown. Here we show that the lungs of patients with COVID-19 contain infected pneumocytes with abnormal morphology and frequent multinucleation. The generation of these syncytia results from activation of the SARS-CoV-2 spike protein at the cell plasma membrane level. On the basis of these observations, we performed two high-content microscopy-based screenings with more than 3,000 approved drugs to search for inhibitors of spike-driven syncytia. We converged on the identification of 83 drugs that inhibited spike-mediated cell fusion, several of which belonged to defined pharmacological classes. We focused our attention on effective drugs that also protected against virus replication and associated cytopathicity. One of the most effective molecules was the antihelminthic drug niclosamide, which markedly blunted calcium oscillations and membrane conductance in spike-expressing cells by suppressing the activity of TMEM16F (also known as anoctamin 6), a calcium-activated ion channel and scramblase that is responsible for exposure of phosphatidylserine on the cell surface. These findings suggest a potential mechanism for COVID-19 disease pathogenesis and support the repurposing of niclosamide for therapy." assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 description "COVID-19 is a disease with unique characteristics that include lung thrombosis(1), frequent diarrhoea(2), abnormal activation of the inflammatory response(3) and rapid deterioration of lung function consistent with alveolar oedema(4). The pathological substrate for these findings remains unknown. Here we show that the lungs of patients with COVID-19 contain infected pneumocytes with abnormal morphology and frequent multinucleation. The generation of these syncytia results from activation of the SARS-CoV-2 spike protein at the cell plasma membrane level. On the basis of these observations, we performed two high-content microscopy-based screenings with more than 3,000 approved drugs to search for inhibitors of spike-driven syncytia. We converged on the identification of 83 drugs that inhibited spike-mediated cell fusion, several of which belonged to defined pharmacological classes. We focused our attention on effective drugs that also protected against virus replication and associated cytopathicity. One of the most effective molecules was the antihelminthic drug niclosamide, which markedly blunted calcium oscillations and membrane conductance in spike-expressing cells by suppressing the activity of TMEM16F (also known as anoctamin 6), a calcium-activated ion channel and scramblase that is responsible for exposure of phosphatidylserine on the cell surface. These findings suggest a potential mechanism for COVID-19 disease pathogenesis and support the repurposing of niclosamide for therapy." assertion.
- 4921 description "" assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 contentSize "5944" assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 contentSize "369" assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 dateCreated "2021-12-10 10:05:51.703731+00:00" assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 dateCreated "2021-12-10 10:05:55.162102+00:00" assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 creation_mode "MANUAL" assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 cite-as "Foglini, Federica. "Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia." ROHub. Dec 10 ,2021. https://w3id.org/ro-id/53cb4ba4-7529-4924-9e30-46d4bf7d55f7." assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 about 4921 assertion.
- ro-crate-metadata.json about 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 assertion.
- 0000-0002-2736-0052 email "federica.foglini@ismar.cnr.it" assertion.
- 0000-0002-2736-0052 name "Federica Foglini" assertion.
- mailto:service-account-generation-service name "service-account-generation-service" assertion.
- -503298211 name "Journal of geophysical research. Biogeosciences" assertion.
- enrichment_service-account-enrichment name "service-account-enrichment" assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 name "Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia" assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 name "Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia" assertion.
- -1411647711 name "Rizzari" assertion.
- -488591808 name "TMEM16F" assertion.
- 4921 name "Biology" assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 contentUrl "https://api.rohub.org/api/ros/53cb4ba4-7529-4924-9e30-46d4bf7d55f7/crate/download/" assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 contentUrl "https://api.rohub.org/api/resources/05b54af3-ce56-4474-9603-9d49e56e97c6/download/" assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 creator mailto:service-account-generation-service assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 creator mailto:service-account-generation-service assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 dateModified "2025-03-05 00:47:51.014292+00:00" assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 dateModified "2021-12-10 10:05:55.163555+00:00" assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 datePublished "2021-12-10 10:05:51.703731+00:00" assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 encodingFormat "application/ld+json" assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 encodingFormat "text/plain" assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 hasPart 05b54af3-ce56-4474-9603-9d49e56e97c6 assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 identifier "https://w3id.org/ro-id/53cb4ba4-7529-4924-9e30-46d4bf7d55f7" assertion.
- 53cb4ba4-7529-4924-9e30-46d4bf7d55f7 license no-permission assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 license no-permission assertion.
- 05b54af3-ce56-4474-9603-9d49e56e97c6 sdDatePublished "2021-12-10 10:05:55.162102+00:00" assertion.
- ro-crate-metadata.json conformsTo 1.1 assertion.
- -864102085 prefLabel "anatomy" assertion.
- -900704710 prefLabel "medicine" assertion.
- 1716096478 prefLabel "pharmacology" assertion.
- -114853210 prefLabel "cytology" assertion.
- 100007899 prefLabel "cell" assertion.
- 100012167 prefLabel "disease" assertion.
- 100001903 prefLabel "americium" assertion.
- 100007917 prefLabel "lung" assertion.
- 100008085 prefLabel "protein" assertion.
- 100012171 prefLabel "drug" assertion.
- 100029579 prefLabel "cell membrane" assertion.
- 100062567 prefLabel "ion channel" assertion.
- 100203566 prefLabel "Congressional Medal of Honor" assertion.
- 100261358 prefLabel "thrombosis" assertion.
- 100372047 prefLabel "pathogenesis" assertion.
- 1004117762 prefLabel "inhibit TMEM16 protein" assertion.
- 100418554 prefLabel "niclosamide" assertion.
- 100844491 prefLabel "syncytium" assertion.
- 12729093 prefLabel "Braga" assertion.